Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20344)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Primary Target | Pathway | GR50 | GRmax | GR_AOC | Death_AUC | GR Hill Coefficient | GEC50 | GR r2 |
---|---|---|---|---|---|---|---|---|---|---|
SUM1315MO2 | Abemaciclib | CDK4/6 | Cell cycle | 0.049304 | -0.1445 | 0.5815 | 0.0291 | 0.5067 | 0.075697 | 0.94514 |
MDA-MB-436 | Dinaciclib | pan CDK | Cell cycle | 0.014324 | -0.1440 | 0.4903 | 0.0235 | 4.8527 | 0.014993 | 0.99777 |
SK-BR-3 | Alpelisib | PI3Ka | PI3K/mTOR | 0.48468 | -0.1428 | 0.3788 | 0.0660 | 0.4911 | 2.8836 | 0.98115 |
HCC1395 | Torin2 | mTOR/ATM/ATR | PI3K/mTOR | 0.014555 | -0.1424 | 0.4547 | 0.0604 | 1.6344 | 0.015746 | 0.98865 |
CAL-120 | Abemaciclib | CDK4/6 | Cell cycle | 0.247 | -0.1408 | 0.4780 | 0.0849 | 0.3730 | 4.696 | 0.95026 |
HCC1806 | Torin2 | mTOR/ATM/ATR | PI3K/mTOR | 0.03581 | -0.1402 | 0.3877 | 0.1005 | 0.9893 | 0.048229 | 0.99141 |
HCC1954 | Vorinostat | HDAC | Misc | 1.426 | -0.1401 | 0.2339 | 0.0833 | 1.2390 | 2.0871 | 0.99732 |
MDA-MB-436 | Topotecan | Topo I | Chemotherapy | 0.0059389 | -0.1398 | 0.8768 | 0.0855 | 1.0160 | 0.0074925 | 0.99666 |
PDX1258 | INK-128 | mTORC1/2 | PI3K/mTOR | 0.044023 | -0.1381 | 0.4558 | 0.0805 | 1.5509 | 0.046987 | 0.98841 |
PDXHCI002 | Taselisib | PI3Ka, g, d | PI3K/mTOR | 0.6002 | -0.1369 | 0.3740 | 0.0320 | 0.4025 | 9.1998 | 0.95462 |
Hs 578T | Etoposide | Topo II | Chemotherapy | 0.41322 | -0.1361 | 0.3770 | 0.1666 | 2.0332 | 0.46109 | 0.99901 |
BT-549 | Cediranib | VEGFR/cKIT | RTK | 3.6412 | -0.1347 | 0.1497 | 0.0414 | 1.3011 | 8.4712 | 0.98092 |
CAL-51 | Bleomycin | Radiation | Misc | 0.1694 | -0.1344 | 0.4855 | 0.0479 | 0.8490 | 0.24736 | 0.9994 |
PDX1258 | Dasatinib | BCR/ABL | MAPK/nRTK | 0.021598 | -0.1339 | 0.7143 | 0.0924 | 1.3176 | 0.024774 | 0.99367 |
T47D | Taxol | Chemo | Chemotherapy | 0.0035285 | -0.1337 | 0.6636 | 0.2505 | 2.2353 | 0.0038792 | 0.99665 |
MCF7 | Torin2 | mTOR/ATM/ATR | PI3K/mTOR | 0.0045641 | -0.1330 | 0.6027 | 0.1279 | 0.9398 | 0.0052657 | 0.98973 |
HCC1806 | Volasertib | PLK | Cell cycle | 0.0027998 | -0.1323 | 0.7262 | 0.2950 | 5.0000 | 0.0029495 | 0.99776 |
CAL-120 | Dinaciclib | pan CDK | Cell cycle | 0.009892 | -0.1320 | 0.5549 | 0.1203 | 4.4157 | 0.010404 | 0.99947 |
HCC1500 | Pictilisib | pan PI3K | PI3K/mTOR | 2.3061 | -0.1317 | 0.2108 | 0.0313 | 0.8635 | 8.2307 | 0.96692 |
HCC1143 | Pictilisib | pan PI3K | PI3K/mTOR | 0.97831 | -0.1291 | 0.3201 | 0.0583 | 0.5213 | 8.0489 | 0.97859 |
MDA-MB-436 | Doxorubicin | Chemo | Chemotherapy | 0.0076138 | -0.1288 | 0.7061 | 0.0611 | 1.3442 | 0.0088093 | 0.99253 |
BT-20 | Bleomycin | Radiation | Misc | 0.4878 | -0.1286 | 0.3764 | 0.0970 | 0.9564 | 0.75174 | 0.99474 |
SK-BR-3 | Pictilisib | pan PI3K | PI3K/mTOR | 0.11448 | -0.1267 | 0.5120 | 0.0731 | 0.6701 | 0.17544 | 0.99532 |
MCF 10A | Taxol | Chemo | Chemotherapy | 0.0026843 | -0.1256 | 0.7023 | 0.2576 | 1.8234 | 0.003018 | 0.9967 |
MDA-MB-231 | Dasatinib | BCR/ABL | MAPK/nRTK | 0.02942 | -0.1256 | 0.6475 | 0.1153 | 0.6812 | 0.03753 | 0.98521 |